We also explored the total and phosphorylated levels of EGFR and HER3, because persistent or constitutively active signaling through RTKs occurs in many solid tumor types including subtypes of breast cancer (HER2) and lung cancer (EGFR), especially when the gene is amplified. This evidence concerns the gene ERBB3 and breast carcinoma.